Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors.
Wolle, P., Hardick, J., Cronin, S.J.F., Engel, J., Baumann, M., Lategahn, J., Penninger, J.M., Rauh, D.(2019) J Med Chem 62: 2843-2848
- PubMed: 30768270 
- DOI: https://doi.org/10.1021/acs.jmedchem.9b00102
- Primary Citation of Related Structures:  
6IB0, 6IB2 - PubMed Abstract: 
The protein kinase MKK7 is linked to neuronal development and the onset of cancer. The field, however, lacks high-quality functional probes that would allow for the dissection of its detailed functions. Against this background, we describe an effective covalent inhibitor of MKK7 based on the pyrazolopyrimidine scaffold.
Organizational Affiliation: 
Faculty of Chemistry and Chemical Biology , TU Dortmund University , Otto-Hahn-Strasse 4a , 44227 Dortmund , Germany.